Stay updated on M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial page.

Latest updates to the M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial page
- ChecktodayChange DetectedPage revision updated from v3.3.3 to v3.3.4, indicating a minor maintenance update. No substantive changes to study content, eligibility criteria, or contact information are apparent.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a new Locations section with the Texas site details and updated the record to Revision 3.3.3; removed the previous Texas Locations entry and the HHS Vulnerability Disclosure.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed from the page.SummaryDifference0.1%

- Check58 days agoChange DetectedThe government funding lapse notice banner was removed from the page. It previously warned that information on the site may not be up to date due to funding issues.SummaryDifference0.4%

- Check72 days agoChange DetectedNo additions or deletions were detected in the provided page comparison.SummaryDifference0.4%

- Check101 days agoChange DetectedUpdated operating-status notice and version to v3.2.0; removed v3.1.0 tag.SummaryDifference4%

Stay in the know with updates to M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial page.